Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FWFBW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,335
Award facts
- Contract value 100% obligated
- $2,335.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $2,335.13 for TYMLOS 80 mcg Dose Pen Injector (1.56 mL) on July 25, 2025. This firm fixed-price delivery order, which is scheduled for completion by July 28, 2025, was issued without set-aside designation and represents a single pharmaceutical product shipment to support federal healthcare operations. The award was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order for TYMLOS, an injectable medication, is consistent with the company's extensive portfolio of pharmaceutical product deliveries, which encompass oncology treatments, contraceptive devices, auto-injectors, vaccines, and specialty medications supporting Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FWFBW?
SPE2DB25FWFBW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FWFBW worth?
The government has obligated $2,335 on SPE2DB25FWFBW.
Is contract SPE2DB25FWFBW an order under another contract?
Yes. SPE2DB25FWFBW is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFBW competed?
The extent of competition for SPE2DB25FWFBW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award